Menstrual Migraine - An opportunity to gain a competitive advantage for triptan manufacturers - Market Research Reports

Printer Friendly

Printed from http://www.researchandmarkets.com/reports/34916

Menstrual Migraine - An opportunity to gain a competitive advantage for triptan manufacturers

Description:

Introduction Menstrual migraine affects over 15 million women across the seven major pharmaceutical markets. At present the disease is managed using a wide variety of pharmacological treatments. However, none of these compounds have an indication specifically for menstrual migraine. With the market relatively untapped, it presents an abundance of commercial opportunities for pharmaceutical manufacturers. Scope - Overview of epidemiology data and patient potential of the menstrual migraine market - Evaluation of current treatments and key unmet needs - Therapeutic and market potential of compounds in clinical trials - Commercial opportunities for compounds currently being used off-label Report Highlights Pharmaceutical manufacturers competing in the migraine market should adopt the standardized definition of menstrual migraine proposed by the International Headache Society. Research and development should focus on compounds that address unmet needs such as migraine specific compounds, short-term prophylactic therapies, treatment refractory patients, and quicker onset of action. Extensive placebo-controlled trials should be initiated to provide robust data showing the true clinical advantages of medications ( i.e. triptans) for menstrual migraine. Other drug manufacturers with anticonvulsant and antidepressant therapies should position their products as an alternative treatment for menstrual migraine. Reasons to Purchase - Assess the patient potential of the menstrual migraine market - Identify the level of unmet need and subsequent market opportunities - Evaluate the therapeutic potential of compounds in clinical trials

Contents:

TABLE OF CONTENTS
About Datamonitor Healthcare 2
About the CNS pharmaceutical analysis team 2
Executive Summary 5
Introduction 5
Scope and coverage of the Brief 5
Key finding about menstrual migraine 6
Disease overview 8
Definition of menstrual migraine 8
Causative factors 9
Prevalence 9
Diagnosis 11
Treatment rate 12
Patient potential 13
Treatment of menstrual migraine 14
Acute treatment 14
Prophylactic treatment 16
Unmet needs in the menstrual migraine market 19
Clinical trials 22
The triptans 22
Market opportunities for other drug manufacturers 34
Anticonvulsants 34
Antidepressants 35
Key Conclusions 37
Appendix 38
Bibliography 38
Websites 42
Disclaimer 43

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/34916

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2
Printed 02/12/2008 04:40:32

Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com

Order information

Please verify that the product information is correct and select the format you require.


Product Name:
Menstrual Migraine - An opportunity to gain a competitive advantage for triptan manufacturers
Web Address:
http://www.researchandmarkets.com/reports/34916
Office Code:
OCIFGLMKQTQ

Report formats

Please enter the quantity of the report format you require.

	Format	Quantity	Price
	Electronic		€2,033.00

Contact information

Please enter all the information below in BLOCK CAPITALS.


	First Name:	Last Name:
	Email Address:
	Job Title:
	Organisation:
	Address:
	City:
	Postal/Zip Code:
	Country:
	Phone Number:
	Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Page 2 of 2
Printed 02/12/2008 04:40:32

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

	American Express
	Diners Club
	Master Card
	Visa


Cardholder Name:

Expiry Date:	/

Card Number:

CVV Security Code:

Issue Date:	/ (Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:


Account number:	83313083
Sort code:	98-53-30
Swift code:	ULSBIE2D
IBAN number:	IE78ULSB98533083313083
Bank Address:	Ulster Bank, 27-35 Main St, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below:
	Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World